Micro CRISPR
↗Vapi, India
Micro CRISPR is a clinical-stage biotechnology company (part of Bilakhia Holdings) focused on the synthetic biology revolution. The company specializes in developing advanced genome editing technologies to create 'living therapeutics' for life-threatening diseases, including cancer, neurodegeneration, and genetic disorders.
Headquartered in Vapi, India, the company operates a sophisticated R&D infrastructure with over 100 PhDs and scientists. Their platform includes proprietary CRISPR-mediated gene editing, autologous and allogenic CAR T-cell therapies, and a robust mRNA vaccine pipeline. They also explore applications in agriculture and xenotransplantation.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:Pre-revenue
Founded:2021
Ownership:private
Status:operating
FUNDING
Stage:Seed/Corporate Backed
Total Raised:$30M+
Investors:Bilakhia Holdings, The Bilakhia Family
PIPELINE
Stage:Preclinical
Lead Drug Stage:Preclinical (Animal trials completed)
Modalities:Cell therapy, Gene therapy, mRNA, CRISPR, Viral vectors (AAV, Lentivirus)
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Bilakhia Holdings
Subsidiaries:Micro Bio Immune Private Limited, Micro Synbio Private Limited
Key Partnerships:M.S. University of Baroda (Academic collaboration), HDFC Bank (Financial partner)
COMPETITION
Position:Emerging
Competitors:Immuneel Therapeutics, ImmunoACT, CRISPR Therapeutics, Intellia Therapeutics, Mammoth Biosciences
LEADERSHIP
Key Executives:
Jacob Changetharayil Benjamin - Director
Himmat Sunder Lal Lodha - Director
Scientific Founders:The Bilakhia Family
Board Members:Jacob Changetharayil Benjamin, Himmat Sunder Lal Lodha
LINKS
Website:microcrispr.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Micro CRISPR. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.